Dent Neurologic

Julia Burket

Suninflam Epilepsy

Suninflam Epilepsy Purpose of the study? This is a dose escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of SIF001, a monoclonal antibody with the potential to treat epilepsy. Detailed Description Nonclinical studies including disease animal model studies and toxicological studies indicate that SIF001 has the potential to be a therapeutic agent for […]

Suninflam Epilepsy Read More »

BMS MINDSET-2

BMS MINDSET-2 Purpose of the study? This is a clinical trial opportunity for adults with mild to moderate dementia due to Alzheimer’s Disease. See the study website and more information below. For more information please contact: Amanda Guerra Clinical Research CoordinatorPhone: 716-558-3492Email: aguerra@dentinstitute.com”    Link to clinicaltrials.gov

BMS MINDSET-2 Read More »

HEALEY ALS Platform Trial – Regimen I NUZ-001

HEALEY ALS Platform Trial – Regimen I NUZ-001 Purpose of the study?  The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen I will evaluate the safety and efficacy of a single study drug, NUZ-001, in participants with ALS.  Link

HEALEY ALS Platform Trial – Regimen I NUZ-001 Read More »

CorEvitas Myasthenia Gravis Registry

CorEvitas Myasthenia Gravis Registry Purpose of the study? The design is a prospective, observational (non-interventional) registry for subjects with myasthenia gravis under the care of a neurology provider. Longitudinal data are collected from both subjects and their treating neurology provider during routine clinical encounters using a structured and standardized data collection method.   Link to clinicaltrials.gov

CorEvitas Myasthenia Gravis Registry Read More »

REVITALYZ: Safety and Efficacy of FT218 in Idiopathic Hypersomnia

REVITALYZ: Safety and Efficacy of FT218 in Idiopathic Hypersomnia About the study? This is a double-blind, placebo-controlled study of the efficacy and safety of FT218. FT218 drug product is a once-nightly formulation of sodium oxybate for extended-release oral suspension. The study will enroll subjects who are diagnosed with idiopathic hypersomnia. Subjects will be eligible to

REVITALYZ: Safety and Efficacy of FT218 in Idiopathic Hypersomnia Read More »

Seratrials

Seratrials: Biological Samples Collection Purpose of the study? SeraTrials is a biotechnology company that partners with major pharmaceutical, biotechnology and diagnostic companies for the development of diagnostic assays and biologicals drug development. SeraTrials requires control blood samples from donors, not currently involved in dosing studies. These blood samples are essential for researchers to further their

Seratrials Read More »

Scroll to Top